Access cutting-edge smoking treatment through this clinical trial at a research site in Dearborn. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Dearborn location
Preparing your pre-screening questions…
Access smoking specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related smoking treatment provided free
Check if you qualify for this smoking clinical trial in Dearborn, MI
No-Cost Study Care
Local to Dearborn
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, 8-week safety follow-up period.
Sponsor: Eli Lilly and Company
Yes, this clinical trial (NCT07223840) has an active research site in Dearborn, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for smoking treatment options in Dearborn, MI, this clinical trial (NCT07223840) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dearborn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced smoking specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.